Your browser doesn't support javascript.
loading
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.
Eichkorn, Tanja; Lischalk, Jonathan W; Hörner-Rieber, Juliane; Deng, Maximilian; Meixner, Eva; Krämer, Anna; Hoegen, Philipp; Sandrini, Elisabetta; Regnery, Sebastian; Held, Thomas; Harrabi, Semi; Jungk, Christine; Herfarth, Klaus; Debus, Jürgen; König, Laila.
Afiliação
  • Eichkorn T; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. tanja.eichkorn@med.uni-heidelberg.de.
  • Lischalk JW; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany. tanja.eichkorn@med.uni-heidelberg.de.
  • Hörner-Rieber J; National Center for Tumor Diseases (NCT), Heidelberg, Germany. tanja.eichkorn@med.uni-heidelberg.de.
  • Deng M; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany. tanja.eichkorn@med.uni-heidelberg.de.
  • Meixner E; Department of Radiation Oncology, Perlmutter Cancer Center at New York, University Langone Health at Long Island, New York, NY, USA.
  • Krämer A; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
  • Hoegen P; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.
  • Sandrini E; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Regnery S; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Held T; German Cancer Consortium (DKTK), Partner Site, Heidelberg, Germany.
  • Harrabi S; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
  • Jungk C; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.
  • Herfarth K; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Debus J; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • König L; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
J Neurooncol ; 162(3): 489-501, 2023 May.
Article em En | MEDLINE | ID: mdl-36598613
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_cobertura_universal Assunto principal: Oligodendroglioma / Astrocitoma / Neoplasias Encefálicas / Glioma Limite: Aged / Humans Idioma: En Revista: J Neurooncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_cobertura_universal Assunto principal: Oligodendroglioma / Astrocitoma / Neoplasias Encefálicas / Glioma Limite: Aged / Humans Idioma: En Revista: J Neurooncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha